Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

NCT02992483

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States
  • Novartis Investigative Site Heidelberg, Victoria, Australia
  • Novartis Investigative Site Nantes, France
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT01594229

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Ucsd /Id# 67350 La Jolla, California, United States
  • University of California, Los Angeles /ID# 67343 Los Angeles, California, United States
  • Emory University Hospital /ID# 67349 Atlanta, Georgia, United States
  • Georgia Regents University /ID# 67342 Augusta, Georgia, United States
View Trial Details
Completed

A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

NCT01794507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 117876 Tucson, Arizona, United States
  • Mayo Clinic /ID# 121495 Jacksonville, Florida, United States
  • Northwestern University Feinberg School of Medicine /ID# 117477 Chicago, Illinois, United States
  • University of Michigan Hospitals /ID# 80353 Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details
Completed

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

NCT00742027

Conditions
Classical Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations
  • City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(2) Duarte, California, United States
  • Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States
  • Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States
  • Rush University Medical Center Divisionof Hem/Onc Research(2) Chicago, Illinois, United States
View all 46 locations
View Trial Details

Related conditions